Summary of Purpose
To determine the benefits and risks of oral anticoagulant therapy in reducing embolic stroke and systemic emboli in patients with atrial fibrillation without rheumatic heart disease.Read More →
The following dates are available for this trial. Trial information last updated on 9 December 2013.
|1 Jul 1985||27 Oct 1999||Unavailable||1 Jun 1991||1 Apr 2012||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All
- Allocation: Randomized
- Purpose: Prevention